Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Outcome in Late-onset Pompe Disease Treated Beyond 36 Months

NCT02824068 is registered in ClinicalTrials.gov with LMU Klinikum as lead sponsor.

NCT NCT02824068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02824068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Outcome in Late-onset Pompe Disease Treated Beyond 36 Months
Lead sponsor
LMU Klinikum
Phase
Observational
Overall status
Completed
Start date
June 1, 2016
Completion date
December 31, 2020
Enrollment
112 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pompe disease